• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination

tetano

Editor, Senior Moderator
Vaccine


. 2022 Aug 22;S0264-410X(22)01027-1.
doi: 10.1016/j.vaccine.2022.08.035. Online ahead of print.
Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination


Kazuyoshi Kurashima[SUP] 1 [/SUP], Tsuyoshi Numano[SUP] 2 [/SUP], Atsuki Yoshino[SUP] 3 [/SUP], Akiko Osawa[SUP] 4 [/SUP], Yotaro Takaku[SUP] 5 [/SUP], Naho Kagiyama[SUP] 6 [/SUP], Tsutomu Yanagisawa[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Antibody levels decrease substantially at 6 months after the BNT162b2 vaccine. The factors influencing titer of antibodies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare workers for coronavirus disease 2019 (COVID-19) is unclear.
Methods: We conducted a 6-month longitudinal prospective study in Japanese healthcare workers in a tertiary care hospital for COVID-19. Participants in the study were tested for the presence of anti-spike protein (SP) IgG antibodies before and at 1 and 6 months after the last vaccination dose.
Results: Among 1076 healthcare workers, 794 received the vaccine, and 469 entered the study. Five were infected with SARS-CoV-2 (none among COVID-19 section workers) by the end of the study and 451 participants were finally analyzed (mean age, 42.5 years; 27.3 % male; 18.8 % COVID-19 section workers). Median SP IgG index values were 0.0, 44.4, and 5.5 before and at 1 and 6 months after the last dose, respectively. Regression analysis revealed a negative correlation of SP IgG antibody levels with age (P < 0.0001), and higher levels in COVID-19 section workers (P = 0.0185) and in females (P = 0.0201).
Conclusion: In healthcare workers at a COVID-19 hospital, IgG antibody titer was substantially lower at 6 months after receipt of the last dose of the BNT162b2 vaccine compared with that 1 month after the last dose, but was better preserved among younger participants, COVID-19 section workers and females.

Keywords: Antibody titre; Coronavirus disease-2019; Healthcare workers; Side effects; Vaccination.
 
Back
Top Bottom